Click a link below to view the mailing archive as if it had been sent to you.
| 2016-02-29 12:15 | | Closely watched AstraZeneca cancer drug fails in mesothelioma and more... |
| 2016-02-28 12:15 | | Sanofi Joins Hands with JDRF for Breakthrough Diabetes Research and more... |
| 2016-02-27 12:15 | | Roche Holding Moves Ahead in Cancer Drugs Race; Wins Expanded FDA Approval for Gazyva and more... |
| 2016-02-27 00:15 | | AZ's deal for Acerta already showing promise as cancer drug wins orphan nod and more... |
| 2016-02-26 12:15 | | Rivals chase Bristol-Myers in cancer immunotherapy drug race and more... |
| 2016-02-26 00:15 | | J&J sells 5% stake in Galapagos after Gilead usurps it as largest shareholder and more... |
| 2016-02-25 12:15 | | In CRISPR patent case, all eyes turn to the judge, a former scientist and more... |
| 2016-02-25 00:15 | | Small study suggests ZMapp may boost Ebola virus survival and more... |
| 2016-02-24 12:15 | | 7 big pharma companies sign on to Parkinson's development group and more... |
| 2016-02-24 00:15 | | Sanofi cuts research staffers in Boston as reorganization looms: report and more... |
| 2016-02-23 12:15 | | What a year it's been already in biotech! and more... |
| 2016-02-23 00:15 | | Senate vote removes major hurdle in Califf’s bid to lead FDA and more... |
| 2016-02-22 12:15 | | Novartis offices in South Korea raided over bribery concerns and more... |
| 2016-02-21 12:15 | | The Top 4 Biopharma Movers of the Past Week and more... |
| 2016-02-20 12:15 | | Sandoz asks Supreme Court to nix 'exclusivity windfall' delaying biosimilar launches and more... |
| 2016-02-19 12:15 | | Bayer close to naming new CEO and Werner Baumann is expected to be the choice and more... |
| 2016-02-19 00:15 | | Bottom-dwelling biotech Hemispherx dumps its CEO and vows to stamp out nepotism and more... |
| 2016-02-18 12:15 | | Drugs to Halt, or Reverse, Deadly Lung Scarring? Third Rock Bets $45M it Can Be Done and more... |
| 2016-02-18 00:15 | | Pfizer downgrades Q4 outlook after $785M DOJ settlement spurred by 'serial whistleblower' and more... |
| 2016-02-17 12:15 | | Regulus Bolsters Argument for Effective Hepatitis C Injection and more... |
| 2016-02-17 00:15 | | Penn, Novartis to unveil $27M cell therapy center and more... |
| 2016-02-16 12:15 | | Pfizer adds $784.6 M charge for Protonix deal to 4Q results and more... |
| 2016-02-15 12:15 | | 3 Biotechs that Could Snap Back and Soar Even Higher and more... |
| 2016-02-14 12:15 | | Eli Lilly and Co.’s 4Q15 Changes in Growth Rate and more... |
| 2016-02-13 12:15 | | Anthrax Vaccine Maker Emergent Hopes To Profit From Biotech Spinoff and more... |
| 2016-02-13 00:15 | | Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12 and more... |
| 2016-02-12 12:15 | | Valeant uses rare accounting maneuver for acquisitions that cushions income and more... |
| 2016-02-12 00:15 | | From 'hit' to candidate: Inside Sanofi's massive compound sharing agreement with AZ and more... |
| 2016-02-11 12:15 | | Superbug review says more vaccines needed to reduce antibiotic use and more... |
| 2016-02-11 00:15 | | Mylan to buy Swedish drugmaker Meda in $7.2 billion deal and more... |
| 2016-02-10 12:15 | | Astellas finally wraps up its $379M deal for Ocata and more... |
| 2016-02-10 00:15 | | Could This Upstart Unseat Intuitive Surgical? and more... |
| 2016-02-09 12:15 | | Alkermes CEO, Richard Pops, On ALKS 5461 And Challenges In Developing New Drugs For Depression and more... |
| 2016-02-09 00:15 | | Juno CEO, CFO get additional 2015 bonuses after $1 billion Celgene deal and more... |
| 2016-02-08 12:15 | | Is the Anti-TNF Lead of AbbVie, Amgen, JNJ Nearing an End? and more... |
| 2016-02-07 12:15 | | How Analysts View Pfizer and Merck After Earnings and more... |
| 2016-02-07 00:15 | | Why Ionis Pharmaceuticals Inc Plunged 36% in January and more... |
| 2016-02-06 00:15 | | A bankrupt KaloBios may still buy Chagas drug that Shkreli wanted to acquire-and-hike and more... |
| 2016-02-05 12:15 | | Why Gathering Health Economic Data for Cancer Drugs is Now Essential and more... |
| 2016-02-05 00:15 | | 4 Can't-Miss Numbers From GlaxoSmithKline's Fourth-Quarter Results and more... |
| 2016-02-04 12:15 | | AstraZeneca warns on profits in 2016 as Crestor patent loss weighs and more... |
| 2016-02-04 00:15 | | GSK's First Biologic Treatment For Asthma - Nucala Holds Multi-Billion Dollar Potential and more... |
| 2016-02-03 12:15 | | Merck beats 4Q profit forecast, misses Street view on sales and more... |
| 2016-02-03 00:15 | | Merck (MRK) Stock Declines Before Wednesday's Earnings and more... |
| 2016-02-02 12:15 | | Sanofi launches hunt for Zika vaccine as disease fears grow and more... |
| 2016-02-02 00:15 | | Gilead accused of manipulating HIV patents and more... |
| 2016-02-01 12:15 | | Express Scripts ditches Valeant diabetes med as part of 2016 formulary shakeup and more... |
| 2016-02-01 00:15 | | 3 Key FDA Decisions Expected in February and more... |
